Welcome to Genafor − Open Services for Medical Research

AREVIR-GenaFor-Meeting 2012

Program

Download Program (PDF)

Donnerstag, 03. Mai 2012

Zeit Vorträge

09:00 - 09:15

Opening Remarks
U. Benjamin Kaup / Stiftung caesar

09:15 - 11:30

Chair: Jens Verheyen
State of ART in HBV /HDV - HOPE
Speakers: Dieter Glebe, Jens Verheyen, Bastian Beggel, Florian Bömmel, Michael Chudy, Valentina Svicher

 

The HOPE-project HBV polymerase as biomarker of antiviral resistance
Dieter Glebe

 

Should HIV-1 Gag mutations be included in genotypic drug resistance scores?
Jens Verheyen

 

Update on geno2pheno[HBV]
Bastian Beggel

 

Newly-Identified Mutations in HBV RT are associated with failures of selected Anti-HBV treatments and induce alteration or stop codon formation in S Antigen
Valentina Svicher

 

Development in Hepatitis B Treatment
Slides missing

Florian van Bömmel

 

Development of an International Reference Preparation for Hepatitis D Virus RNA
Michael Chudy

11:30 - 11:45

Coffee break

11:45 - 13:30

Chair: Rolf Kaiser
State of ART in HCV - PEPSI
Speakers: Volker Lohmann, Thomas von Hahn, Bastian Beggel, Anna Marie Sikorski

 

HCV: Basic virology, drug targets and -resistance
Volker Lohmann

 

New challenges in the treatment of chronic hepatitis C virus infection
Thomas von Hahn

 

Hepatitis C Virus Resistance Testing
Anna Maria Sikorski

 

geno2pheno[hcv]
Bastian Beggel

 

COMET: Rapid and reliable HCV subtype predictor
Daniel Struck

13:30 - 14:30

Lunch

14:30 - 15:30

Chair: Martin Stürmer, Stefan Esser
HIV-1 -2 diagnostics and therapy - state of ART,
HIV-2 Algorithm (HIV-GRADE / CHAIN activities
Speakers: Jean Ruelle, Martin Obermeier

 

HIV-Grade
Martin Obermeier

 

HIV-2: diagnostic tools and antiretroviral therapy
Jean Ruelle

15:30 - 16:30

Chair: Patrick Braun, Tobias Goeser
HIV-1 viral load determination and therapeutic consequences?
HCV viral load determination and therapeutic consequences?
Speakers: Thomas Berg, Christoph Jochum

 

Low-Level Viremia in HIV
Martin Obermeier

 

HCV Viral Load Determination and Therapeutic Consequences?
Christoph Jochum

16:30 - 17:00

Coffee break

17:00 - 18:00

Chair: Martin Däumer, Alexander Thielen
NGS (Next Generation Sequencing) and diagnostics
Speakers: Niko Beerenwinkel, Alex Thielen, Francesca Ceccherini-Silberstein

 

Deep sequencing in clinical virology
Martin Däumer

 

NGS in clinical Italian practice: impact of minor quasispecies on antiretroviral drug resistance and viral tropism
Daniele Armenia

 

Freitag, 04. Mai 2012

Zeit Vorträge

09:00 - 09:15

Patient’s view

09:15 - 11:30

Chair: Francesca Incardona, Thomas Lengauer
EuResist
EuResist present and future: The EuResist database and interpretation system HIV resistance, treatment perspectives and data collection in Russia, Ethiopia, India, Tanzania, South Africa

 

EuResist Network Present and future
Francesca Incardona

 

EuResist in Africa: the EDCTP ENNEA project
Maurizio Zazzi

 

EucoHIV project
Rolf Kaiser

 

The EuResist engine in Brazil: a preliminary comparative study
Helena Duani, Isadora S. B. Saraiva

 

History-alignment Models for Bias-aware Prediction of Virological Response to HIV Combination Therapy
Jasmina Bogojeska

11:30 - 11:45

Coffee break

11:45 - 13:30

Chair: Dieter Häussinger, Herbert Pfister
RESINA and RKI-seroconverter study
Speakers: Mark Oette, Alejandro Pironti, Sybille Somogyi, Klaus Jansen, Björn Jensen, Jens Verheyen, Glenn Lawyer

 

Primary HIV Drug Resistance: The RESINA Study
Mark Oette

 

A Tool for Predicting the Success of First-Line Antiretroviral Therapies
Alejandro Pironti

 

Trends in transmission of HIV-1 subtypes and recombinants
Sybille Somogyi

 

The German HIV-1 Seroconverter cohort study
Klaus Jansen

 

Should HIV-1 Gag mutations be included in genotypic drug resistance scores?
Jens Verheyen

 

Phylodynamics of HIV in Germany and Europe
Glenn Lawyer

13:30 - 14:30

Lunch

14:30 - 15:30

Chair: Nadine Lübke, Hauke Walter
HIV-1 tropism determination and therapy consequences
Speakers: Martin Obermeier, Thomas Klimkait, Chris Verhofstede, Eva Heger, Nico Pfeifer

 

Multicenter comparison of genotypic tropism testing: results from viral RNA and proviral DNA
Martin Obermeier

 

Correlation of HIV tropism with immunological response under HAART
Thomas Klimkait

 

Coreceptor Switch in Treatment Naive Patients
Chris Verhofstede

 

New methods and new data to improve HIV coreceptor usage prediction
Nico Pfeifer

15:30 - 18:00

Workshop sessions

 

HIV-resistance and tropism diagnostics and therapy consequences
Stefan Scholten, Alejandro Pironti, Hauke Walter

 

HIV Tropism
Björn Jensen, Martin Obermeier, Alexander Thielen

 

HBV resistance and escape
Andreas Erhardt, Ke Zhang, Bastian Beggel

 

HCV resistance
Nazifia Quirishi, Nico Pfeifer, Saleta Sierra Aragon

18:00 -

Summary of the workshops and closing remarks

Rolf Kaiser

Download Program (PDF)